Charles River Laboratories management check

CRL · Health Care · Life Sciences Tools & Services · CEO Birgit Girshick (since the last proxy; previously Mr. Foster)

Filings as of

56
Management score, ranked 375th of 487 · 47th of 60 in Health Care3 good · 2 to watch · 2 flaggedStrongest: clean books · Weakest: CEO cost · Best and worst run in Health Care →

The seven checks

  • Flag

    Have owners done well?

    Trailed its chosen peersOwners$81Peers$148

    What $100 became since fiscal 2021

    016th
    Detail

    $100 invested at the start of fiscal 2021 grew to $81, against $148 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    9376th
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.86 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Flag

    What does the CEO cost owners?

    Paid in a loss-making year

    $15.4m pay · −$144.3m net income, FY2025

    0.1%1%3%10%loss
    016th
    Detail

    $15.4m of reported pay in fiscal 2025, a year the company lost $144.3m.

  • Watch

    Do they own the stock?

    New CEO since the proxy

    Birgit Girshick: 35,485 shares

    6 mo: ▲ $3k bought · ▼ $52.1m sold

    ——
    Detail

    Birgit Girshick filed as Chief Executive Officer after the last proxy (which named Mr. Foster) and holds 35,485 shares. Their pay will be in the next proxy. 6 insiders sold $52.1m in the last six months, against $3k bought. 10 of 21 sales ran on pre-arranged 10b5-1 plans.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 51m2025 · 50m

    Diluted shares −1.9% a year; flagged above +2%

    0%10%20%

    Stock pay 1.8% of revenue

    7365th
    Detail

    Diluted shares changed -1.9% a year over the last three fiscal years. Stock-based pay was 1.8% of revenue in the latest year.

  • Watch

    Is leadership stable?

    New CEO: Birgit Girshick

    9 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Mr. Foster → Birgit Girshick (new)

    7046th
    Detail

    Birgit Girshick has filed as CEO since the last proxy. CEO in the pay table: Mr. Foster. 9 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed March 31, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$20.6m$41.2m$10020212022202320242025$81$148

Pay tied most to Non- GAAP EPS

Other key measuresRevenueNon-GAAP EPSNon-GAAP Operating Income

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Mr. Foster$15.4m$24.9m$3.6m$81$148−$144.3m
2024—$13.5m$3.1m$3.5m$74$129$10.3m
2023—$14.1m$20.5m$3.7m$94$126$474.6m
2022—$13.4m$10.7m$3.3m$87$124$486.2m
2021—$13.7m$41.2m$4.4m$147$126$391.0m

Insiders and the CEO's stakeSelling

Chief Executive Officer
Birgit Girshick
Shares held
35,485
Latest Form 4
Aug 19, 2026

6 insiders sold $52.1m in the last six months, against $3k bought. 10 of 21 sales ran on pre-arranged 10b5-1 plans.

Open-market trades by officers and directors since May 21, 2026.

  • BoughtGlenn ColemanEVP & Chief Financial Officer$3kSep 30, 2026
  • SoldJames C FosterDirector · 10b5-1 plan$43.3mOct 22, 2026
  • SoldShannon M ParisottoCEVP, Disc & Safety Assessment · 10b5-1 plan$4.0mOct 21, 2026
  • SoldBirgit GirshickChief Executive Officer · 10b5-1 plan$1.8mAug 11, 2026

Leadership and governance on file

20222023202420252026Leadership 13Votes 5
All 13 filings

Latest shareholder vote results: May 11, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $583.4m returned to owners in buybacks and dividends, 47% of net income, and $358.1m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
−$144.3m$170.9m$486.2m20212022202320242025Shares51m51m51m52m50m
Show the figures
Fiscal year20212022202320242025
Revenue$3.5bn$4.0bn$4.1bn$4.0bn$4.0bn
Net income$391.0m$486.2m$474.6m$22.2m−$144.3m
Stock-based pay$71.5m$73.6m$72.0m$69.9m$71.1m
Buybacks$40.7m$38.7m$24.2m$119.2m$360.7m
Dividends—————
Diluted shares51m51m51m52m50m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.